ProCE Banner Activity

NSCLC Biomarkers ExpressPoints: Expert Insights on New Targets, Testing Options, and Personalized Treatment

Slideset Download
Download this short summary slideset of key takeaways from a live CCO Webinar featuring a medical oncologist and molecular pathologist discussing established and emerging biomarkers critical to optimal treatment of patients with advanced NSCLC.

Released: October 21, 2020

Expiration: October 20, 2021

No longer available for credit.

Share

Faculty

Joel W. Neal

Joel W. Neal, MD, PhD

Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California

Lauren L. Ritterhouse

Lauren L. Ritterhouse, MD

Assistant Professor
Department of Pathology
Harvard Medical School
Associate Director
Center for Integrated Diagnostics
Department of Pathology
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Joel W. Neal, MD, PhD

Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California

Lauren L. Ritterhouse, MD

Assistant Professor
Department of Pathology
Harvard Medical School
Associate Director
Center for Integrated Diagnostics
Department of Pathology
Massachusetts General Hospital
Boston, Massachusetts